Peter Unge
Oprichter bij Cinclus Pharma Holding AB
Vermogen: 6 M $ op 30-06-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Stig Lennart Hansson | M | 68 |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 10 jaar |
| Marie Helena Levander | F | 67 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 3 jaar |
| Torbjörn Mattias Koivisto | M | 55 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 7 jaar |
| Nina Rawal | M | 45 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 2 jaar |
| Anders Öhberg | M | 44 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 8 jaar |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 8 jaar |
| Christer Ahlberg | M | 53 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 3 jaar |
| Kajsa Larsson | M | 58 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden. | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Zweden | 8 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Peter Unge
- Persoonlijk netwerk
